Healthcare stocks have turned solidly higher in late trade with
the NYSE Healthcare Sector Index rising about 0.4% and shares of
healthcare companies in the S&P 500 adding around 0.8% as a
In company news, EDAP SA (
) is up 7.8% at $2.89 a share after the French medical-device
company said it has received the CE Mark from European regulators
for its Focal.One robotic tool to treat prostate cancer.
The device combines the latest imaging tools - including MRI
localization and contrast-enhanced ultrasound control - with the
high-intensity focused ultrasound to target and then destroy tumors
with preciously focused heat.
Marketing approvals for the United States are pending.
In other sector news,
(+) CBMX, Said prenatal testing has shown a "significant uptick"
during the six months since data from two National Institutes of
Health studies showing the value of chromosomal microarray analysis
(-) GNMK, Reduces projected FY13 revenue by $5 mln from its
previous guidance, now expecting around $30 mln in yearly revenue.
Analysts, on average, have been looking for around $35 mln in
revenue this year by the molecular diagnostics company.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.